Navigation Links
Clinical trial to test stem cell approach for children with brain injury

A unique clinical trial will gauge the safety and potential of treating children suffering traumatic brain injury with stem cells derived from their own bone marrow starting early next year at The University of Texas Medical School at Houston and Memorial Hermann Children's Hospital.

The clinical trial is the first to apply stem cells to treat traumatic brain injury. It does not involve embryonic stem cells.

"There is no reparative treatment for traumatic brain injury," said principal investigator Charles Cox, M.D., The Children's Fund, Inc. Distinguished Professor in Pediatric Surgery and Trauma at the medical school. "All we can do now is try to prevent secondary damage by relieving pressure on the brain caused by the initial injury."

Unlike bone, muscle and other organs, the brain does not repair itself effectively. Traumatic brain injury victims can regain some function through rehabilitation. Studies show between 15 and 25 percent of children suffering severe traumatic brain injury die, and survivors of even moderate injury often are devastated for life.

Approved by the U.S. Food and Drug Administration and the university's Committee for the Protection of Human Subjects (CPHS), the clinical trial builds on laboratory and animal research indicating that bone-marrow derived stem cells can migrate to an injured area of the brain, differentiate into new neurons and support cells, and induce brain repair.

"This would be an absolutely novel treatment, the first ever with potential to repair a traumatically damaged brain," said James Baumgartner, M.D., associate professor of pediatric neurosurgery and co-principal investigator on the project.

As a Phase I clinical trial, the project's first emphasis is to establish the safety of the procedure, with a secondary goal of observing possible therapeutic effects.

Cox and Baumgartner have permission to recruit 10 head injury patients to the study between th
'"/>

Source:University of Texas Health Science Center at Houston


Page: 1 2 3

Related biology news :

1. International trial of two microbicides begins
2. Use of PET can reduce, may eliminate more strenuous drug development trials with animals
3. HIV vaccine trial breaks ground for future research
4. Roche clinical trial registry and results database launched
5. NIAID begins clinical trial of West Nile virus vaccine
6. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
7. Compound might defeat African sleeping sickness, clinical trial beginning this month
8. Why were the HIV prevention trials in commercial sex workers abandoned?
9. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
10. Industrial contaminants spread by seabirds in High Arctic, new Canadian study shows
11. Results of worlds first gene therapy trial for arthritis show approach safe, feasible

Post Your Comments:
(Date:11/23/2009)..., 2009 Applied mathematicians dissected the morph... characteristic long leaf with a saddle-like arc m...es. The simple cause of the lily,s fan-like shapee...fferential growthwas revealed by using an equally ...yi Liang, a postdoctoral student at Harvard,s Scho...
(Date:11/23/2009)...suggests that a common oral bacterium may exacerba...ols et al, "Unique Lipids from a Common Human Bact...e of Enhancing Autoimmunity," appears in the Decem...gy . , Multiple sclerosis (MS), a disease where ...d, affects nearly 1 in 700 people in the United St...
(Date:11/23/2009)... A USDOE and USDA study concluded that 50 million ...d pasture could be converted from current uses to ...hgrass, from which biomass could be harvested for ...oduction of a perennial grass monoculture from whi...nnually is expected to require nitrogen fertilizer...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Factors from common human bacteria may trigger multiple sclerosis 2Switchgrass produces biomass efficiently 2AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 1AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 2AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 3MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 1MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 2MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 3Michigan Health 26 Hospital Association Elects 2009 Officers and Board Members 49957 1Michigan Health 26 Hospital Association Elects 2009 Officers and Board Members 49957 2
...ide in designated Special Areas of Conservation th...rnwall, might be at risk from pile driving. The fr...e with their ability to communicate, find food and... their behaviour, health and their ability to bree... might be particularly vulnerable , Recently more...
...nth,s issue of Angiology shows that supplementatio...en-all) improves blood flow to the muscles which s...of 113 participants demonstrated that Pycnogenol s...thletes and healthy, normal individuals. , "With ...a profound breakthrough and extremely significant ...
...e found that a method they developed to screen bod...eir genetic blueprint is twice as accurate at spot...ith a microscope. , The screen, developed by Sar... separates cells from fluid, then sifts through th...sociated with cancer. , Reporting in the June 1 ...
Other Biology News:South Pacific plant may be missing link in evolution of flowering plants 2Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics 2Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics 3Gene screen for breast cancer better than pathologist's 'eye' 2
(Date:11/24/2009)...KJAVIK,Iceland,November24/PRNewswire-FirstCall/--d...eapprovalofallofits,"firstday"motionsbytheU.S.Bank...yCourt").deCODElastweekfiledavoluntarypetitionfor,...ewiththe,BankruptcyCourt. , Theordersissuedby...ateitsbusinessduringtheChapter11proceedings.Inpart...
(Date:11/24/2009)...MATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neuroge...cusedondevelopingandcommercializingnovelpainmanage...sidentandChiefExecutiveOfficer,isscheduledtopresen...obeheldDecember1-2,2009atTheNewYorkPalaceHotelinNe...,ChiefFinancialOfficer,willbeavailabletorespondtoq...
(Date:11/24/2009)...TTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.anno...entAuthority(OPDA)wererecentlyawarded$2millionbyWa...d(CERB)inaprivate/publicpartnershiptoconstructthes...nCounty,WA. ,, "Thisinvestmentwillsignificantly...reenjobstoLincolnCounty,"saidBlueMarbleEnergyCEOKe...
(Date:11/24/2009)...maryefficacyendpointhasbeenmetforpatientswithadvan...BECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZentar...lbiopharmaceuticalcompanyfocusedonendocrinetherapy...aPhase2studywithitstargetedcytotoxicpeptideconjuga...orrecurrentendometrialcancer.Inapersonalizedhealth...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
..., April 7 /PRNewswire-Asia-FirstCall/ -- China Sky...e Company") (Nasdaq: CSKI ), a,leading fully int...counter drugs in the People,s Republic of China ("...ion filed with the Securities and,Exchange Commiss..., 2009, is,related to a technical non-cash account...
...Eindhoven University of Technology (TU/e) have dev...l reactions. For the first time they used mechanic...e most fundamental concepts in chemistry. This all...anical force. This discovery paves the way to deve...nder the influence of mechanical tension. The resu...
...eversed hemophilia in mice , , GAITHERSBURG, Md.,...e publication of a new research article, " Trans -...for Production of Therapeutic Proteins In Vivo," ...scribes a novel RNA therapy technique in which an ...ne "hijacks" the albumin, causing it to produce th...
Other Biology Technology:China Sky One Medical, Inc. Provides Update on Filing Form 10-K 2China Sky One Medical, Inc. Provides Update on Filing Form 10-K 3A molecular ripcord for chemical reactions 2VIRxSYS Publishes New Study on RNA Therapy 2
Rabbit Anti-Phospho RNA Polymerase II (S5) Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Anti-Acetylcholinesterase Monoclonal Antibody, Unconjugated, Clone AE-2 from CHEMICON
Power Supply for i-MyRun from Cosmo Bio Co., Ltd.
...oftware for JASCO HPLC systems. , Integrated In...te can be configured with a vast number of contro...ovides a completely integrated system to control i...nd record all instrument settings with each run. ,...
Biology Products: